Cargando…

The systolic paradox in hypertrophic cardiomyopathy

OBJECTIVE: We explored cardiac volumes and the effects on systolic function in hypertrophic cardiomyopathy (HCM) patients with left ventricular hypertrophy (HCM LVH+) and genotype-positive patients without left ventricular hypertrophy (HCM LVH−). METHODS: We included 180 HCM LVH+, 100 HCM LVH− patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haland, Trine F, Hasselberg, Nina E, Almaas, Vibeke Marie, Dejgaard, Lars A, Saberniak, Jørg, Leren, Ida S, Berge, Knut Erik, Haugaa, Kristina H, Edvardsen, Thor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Heart 2017
Materias:	Heart and Cardiomyopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471858/ https://www.ncbi.nlm.nih.gov/pubmed/28674623 http://dx.doi.org/10.1136/openhrt-2016-000571

Ejemplares similares

Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy
por: Haland, Trine F., et al.
Publicado: (2016)

Data on exercise and cardiac imaging in a patient cohort with hypertrophic cardiomyopathy
por: Dejgaard, Lars A., et al.
Publicado: (2017)

Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation
por: Hasselberg, Nina Eide, et al.
Publicado: (2018)

Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia
por: Saberniak, Jørg, et al.
Publicado: (2017)

Contractility surrogates derived from three-dimensional lead motion analysis and prediction of acute haemodynamic response to CRT
por: Ross, Stian, et al.
Publicado: (2018)

Exercise and myocardial injury in hypertrophic cardiomyopathy
por: Cramer, G Etienne, et al.
Publicado: (2020)

Copper chelation in patients with hypertrophic cardiomyopathy
por: Reid, Anna, et al.
Publicado: (2022)

The role of echocardiography in management of hypertrophic cardiomyopathy
por: Haland, Trine F., et al.
Publicado: (2019)

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017)

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity
por: de Feria, Alejandro E, et al.
Publicado: (2021)

Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy
por: Camaioni, Claudia, et al.
Publicado: (2020)

Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy
por: Salazar-Mendiguchía, Joel, et al.
Publicado: (2020)

Results of comprehensive diagnostic work-up in ‘idiopathic’ dilated cardiomyopathy
por: Broch, Kaspar, et al.
Publicado: (2015)

Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy
por: Gastl, Mareike, et al.
Publicado: (2020)

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
por: Grall, Sylvain, et al.
Publicado: (2014)

The influence of aortoseptal angulation on provocable left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
por: Critoph, Christopher Howell, et al.
Publicado: (2014)

Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy
por: Lopes, Luis R, et al.
Publicado: (2015)

Heart Rate Recovery in Patients With Hypertrophic Cardiomyopathy
por: Patel, Vimal, et al.
Publicado: (2014)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
por: Adalsteinsdottir, Berglind, et al.
Publicado: (2020)

Functional, morphological and electrocardiographical abnormalities in patients with apical hypertrophic cardiomyopathy and apical aneurysm: correlation with cardiac MR
por: Suwa, Kenichiro, et al.
Publicado: (2014)

Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
por: Sugrue, Alan, et al.
Publicado: (2017)

Prognostic significance of repeated brain natriuretic peptide measurements after percutaneous transluminal septal myocardial ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy
por: Akita, Keitaro, et al.
Publicado: (2018)

Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy
por: Javidgonbadi, Davood, et al.
Publicado: (2019)

Artificial intelligence-assisted interpretation of systolic function by echocardiogram
por: Yamaguchi, Natsumi, et al.
Publicado: (2023)

Pseudo-Paradoxical Jet Flow in a Patient with Midventricular Obstructive Hypertrophic Cardiomyopathy
por: Misumi, Ikuo, et al.
Publicado: (2020)

Significant reduction of left atrial volume concomitant with clinical improvement after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy, and its precise detection with multidetector CT
por: Maekawa, Yuichiro, et al.
Publicado: (2016)

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
por: Lee, Dawn, et al.
Publicado: (2014)

Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
por: Mealing, Stuart, et al.
Publicado: (2016)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Exercise is Associated With Impaired Left Ventricular Systolic Function in Patients With Lamin A/C Genotype
por: Skjølsvik, Eystein T., et al.
Publicado: (2020)

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
por: Lauppe, Rosa Elisabeth, et al.
Publicado: (2021)

Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy
por: Graziosi, Maddalena, et al.
Publicado: (2022)

Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy
por: Damy, Thibaud, et al.
Publicado: (2016)

Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy
por: Hammersley, Daniel J, et al.
Publicado: (2022)

Repetitive squatting exercise as a diagnostic predictor in patients with dilated cardiomyopathy
por: Sveric, Krunoslav Michael, et al.
Publicado: (2018)

Systematic review and meta-analysis of prolactin and iron deficiency in peripartum cardiomyopathy
por: Cherubin, Sinaida, et al.
Publicado: (2020)

Aetiological and morphological spectrum of cardiomyopathies in French Guiana: a retrospective study
por: Leménager, Paul, et al.
Publicado: (2020)

Association between right ventricular strain and outcomes in patients with dilated cardiomyopathy
por: Liu, Tong, et al.
Publicado: (2021)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy
por: Tateishi, Emi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_288sd2bi0g72asm5skcg0ghaqk